NCT02103686View on ClinicalTrials.gov

Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Healthy
Interventions
DRUG

Lyrica

DRUG

Experimental drug

sustained release formulation of pregabalin

DIETARY_SUPPLEMENT

High fat meal

DIETARY_SUPPLEMENT

fasted

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT02103686 - Study for Comparing The Pharmacokinetics of A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation and to Assess the Effect of High Fat Diet in Healthy Male Subjects | Biotech Hunter | Biotech Hunter